Jurkat/Human CD8 alpha & CD8 beta Stable Cell Line

• Genetically modified cell lines best reflect MOA (Mechanism of Action)
• Higher activity and larger assay window for robust and reproducible cell-based bioassay
• Comprehensive application data to support assay development and validation
• Full tracible record, stringent quality control and validated cell passage stability
• Parental cell line legally obtained from internationally recognized cell resource bank and commercially licensed
• Global commercial license assistance whenever regulatory filing is required

The Jurkat/Human CD8 alpha & CD8 beta Stable Cell Line was engineered to express the full length human CD8 alpha (Uniprot: P01732) and CD8 beta (Uniprot: P10966). Surface expression of human CD8 alpha & CD8 beta was confirmed by flow cytometry.

• Useful for cell-based CD8 alpha & CD8 beta binding assay

Suspension

Hygromycin B (20 μg/mL)

RPMI-1640 + 10% FBS

Serum-free cell cryopreservation medium

1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium

Frozen in liquid nitrogen.

Negative

Negative

See data sheet for detailed culturing and assay protocol.